Literature DB >> 33457029

Recurrent Herpes Zoster Ophthalmicus Preceded by Anabolic Steroids and High-Dose L-Arginine.

Stephen A LoBue1,2, Adam Goldman1, Richard A Giovane3, Stacy M Carlson4, Michael Bivona1, Sinan Albear1, Thomas D LoBue2.   

Abstract

PURPOSE: To report a case of a 34-year-old male with recurrent herpes zoster ophthalmicus (HZO) preceded by a 6-week cycle of anabolic steroids and high-dose amino acid supplementation. Case Presentation. A 34-year-old man presented to our institution for left eye pain for one week associated with a vesicular rash in the V1 dermatome, respecting the midline. The patient had no significant past medical or past ocular history, including systemic immunosuppressive agents or HIV. However, prior to the onset of his symptoms the patient had completed a 6-week course of anabolic steroids including trenbolone, deca-durabolin, and testosterone as well as high-dose arginine supplementation averaging more than 40 grams a day. The best-corrected vision was 20/25 OS with slit-lamp examination remarkable for punctate staining and pseudodendrites at 6 o'clock, outside the visual axis. The patient was treated with oral acyclovir 800 mg five times a day for seven days along with prednisolone QID and moxifloxacin QID which was tapered over a month. Four months after resolution, the patient developed a recurrent HZO keratitis preceded by another cycle of anabolic steroids and amino acid supplementation.
CONCLUSION: In vitro L-arginine supplementation has been associated with the proliferation and virulence of a variety of herpes viruses. Anabolic steroids have also been demonstrated by various studies to negatively affect cell-mediated immunity necessary to prevent viral infection. Thus, it is possible that anabolic steroids in conjunction with increased L-arginine intake may have precipitated a recurrent HZO in a previously healthy, immunocompetent individual.
Copyright © 2020 Stephen A. LoBue et al.

Entities:  

Year:  2020        PMID: 33457029      PMCID: PMC7785356          DOI: 10.1155/2020/8861892

Source DB:  PubMed          Journal:  Case Rep Ophthalmol Med


  21 in total

1.  Herpes zoster recurrences more frequent than previously reported.

Authors:  Barbara P Yawn; Peter C Wollan; Marge J Kurland; Jennifer L St Sauver; Patricia Saddier
Journal:  Mayo Clin Proc       Date:  2011-01-10       Impact factor: 7.616

2.  The significance of the arginine and arginase of tears in experimentally-induced herpes simplex corneae.

Authors:  I L Kahán; K Hajas; A Halász
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-01-15

3.  Amino acid requirement of adenovirus multiplication.

Authors:  R Wigand; G Kümel
Journal:  J Gen Virol       Date:  1978-05       Impact factor: 3.891

4.  The incidence of herpes zoster in a United States administrative database.

Authors:  Ralph P Insinga; Robbin F Itzler; James M Pellissier; Patricia Saddier; Alexander A Nikas
Journal:  J Gen Intern Med       Date:  2005-08       Impact factor: 5.128

5.  Factors associated with age of onset of herpes zoster ophthalmicus.

Authors:  Annie Y Chan; Christopher D Conrady; Kai Ding; Justin D Dvorak; Donald U Stone
Journal:  Cornea       Date:  2015-05       Impact factor: 2.651

6.  Induction of arginases I and II in cornea during herpes simplex virus infection.

Authors:  S K Mistry; M Zheng; B T Rouse; S M Morris
Journal:  Virus Res       Date:  2001-03       Impact factor: 3.303

7.  Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Rafael Harpaz; Ismael R Ortega-Sanchez; Jane F Seward
Journal:  MMWR Recomm Rep       Date:  2008-06-06

Review 8.  Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.

Authors:  Thomas J Liesegang
Journal:  Ophthalmology       Date:  2008-02       Impact factor: 12.079

Review 9.  Risk assessment for the amino acids taurine, L-glutamine and L-arginine.

Authors:  Andrew Shao; John N Hathcock
Journal:  Regul Toxicol Pharmacol       Date:  2008-01-26       Impact factor: 3.271

10.  Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine.

Authors:  Stephen A LoBue; Prashant Tailor; Stacy M Carlson; Fukutaro Mano; Richard A Giovane; Erin Schaefer; Thomas D LoBue
Journal:  Am J Ophthalmol Case Rep       Date:  2019-08-20
View more
  1 in total

1.  Varicella-Zoster Virus Encephalitis in an Immunocompetent Adult with Disseminated Cutaneous Herpes Zoster after Testosterone Booster Supplements: Case Report.

Authors:  Ghada Alhayaza; Abdullah Al-Omair; Hind M Almohanna
Journal:  Case Rep Dermatol       Date:  2022-06-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.